- Sort by Sort ascending
- Titolo di lavoro
- Site
- Posizione
- Divisione
- Business
- Area funzionale Sort descending
- Data di pubblicazione
| Titolo di lavoro | Site | Posizione | Divisione | Business | Area funzionale Sort descending | Data di pubblicazione |
|---|---|---|---|---|---|---|
| Associate Marketing | Shanghai (Shanghai) | Cina | International | Innovative Medicines | Marketing | Lug 08, 2024 |
| 区域市场组经理 | Xian (Shanxi Province) | Cina | International | Innovative Medicines | Marketing | Lug 28, 2024 |
| (高级)区域市场经理 | Xian (Shanxi Province) | Cina | International | Innovative Medicines | Marketing | Set 05, 2024 |
| (高级)地区经理 | Hefei (Anhui Province) | Cina | International | Innovative Medicines | Marketing | Set 12, 2024 |
| Senior Area Marketing Manager | Guangzhou (Guangdong Province) | Cina | International | Innovative Medicines | Marketing | Ott 15, 2024 |
| Business Excellence & Execution IM Head, Mexico | INSURGENTES | Messico | International | Innovative Medicines | Marketing | Ott 17, 2024 |
| Tax Specialist (m/w/d) | Schaftenau | Austria | Finance | CTS | Audit e finanza | Lug 22, 2024 |
| Tax Manager m/w/d) | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | Germania | Finance | Corporate | Audit e finanza | Ott 16, 2024 |
| R2R Specialist - Inventory | Selangor | Malaysia | Finance | CTS | Audit e finanza | Lug 28, 2024 |
| BPA Planning Process, RLT | Baarle Nassau | Paesi Bassi | Finance | Innovative Medicines | Audit e finanza | Ago 05, 2024 |
| Financial Accounting Specialist (m/w/d) | Schaftenau | Austria | Finance | CTS | Audit e finanza | Set 13, 2024 |
| Financial Control & Compliance (FC&C) Lead | Amiria | Egitto | Finance | CTS | Audit e finanza | Mag 23, 2024 |
| Corporate Tax Manager | Amiria | Egitto | Finance | Corporate | Audit e finanza | Mag 31, 2024 |
| Senior Accountant, Tax | Shanghai (Shanghai) | Cina | Finance | Corporate | Audit e finanza | Ago 29, 2024 |
| P2P & T&E Specialist (Japanese speaker) | Selangor | Malaysia | Finance | CTS | Audit e finanza | Giu 05, 2024 |
| P2P & T&E Business Partner (Japanese speaker) | Selangor | Malaysia | Finance | CTS | Audit e finanza | Giu 12, 2024 |
| R2R Senior Specialist GL & Reporting | Selangor | Malaysia | Finance | CTS | Audit e finanza | Giu 13, 2024 |
| Global Digital FRA Automation Lead | Hyderabad (Office) | India | Finance | Corporate | Audit e finanza | Giu 20, 2024 |
| FP&A Manager | İstanbul Kavacık | Turchia | Finance | Innovative Medicines | Audit e finanza | Giu 28, 2024 |
| S2P Business Partner (Korean speaker) | Selangor | Malaysia | Finance | CTS | Audit e finanza | Set 24, 2024 |
| Senior FRA Specialist GL | Prague | Repubblica Ceca | Finance | CTS | Audit e finanza | Set 26, 2024 |
| Site Finance Head | Morris Plains | USA | Finance | Innovative Medicines | Audit e finanza | Ott 04, 2024 |
| R2R Lead Israel | Israel | Israele | Finance | CTS | Audit e finanza | Set 16, 2024 |
| Financial Analyst - SoD Ops | Hyderabad (Office) | India | Finance | Corporate | Audit e finanza | Set 17, 2024 |
| Comptable Général(e) Expérimenté(e) H/F | Paris Headquarter (Novartis Pharma S.A.S.) | Francia | Finance | CTS | Audit e finanza | Set 27, 2024 |
| BPA & R2R Analyst | Amsterdam | Paesi Bassi | Finance | Innovative Medicines | Audit e finanza | Set 04, 2024 |
| R2R Senior Specialist | Bucuresti | Romania | Finance | CTS | Audit e finanza | Set 05, 2024 |
| Associate Director, US Federal and State Tax Reporting | East Hanover | USA | Finance | Corporate | Audit e finanza | Set 06, 2024 |
| Revenue Deduction & Accounting Statutory Lead | Warsaw | Polonia | Finance | CTS | Audit e finanza | Ott 10, 2024 |
| R2R Team Lead - GL & Reporting | Selangor | Malaysia | Finance | CTS | Audit e finanza | Ott 10, 2024 |
| BPA (Budget & Planning Analyst) | İstanbul Kurtköy | Turchia | Finance | Innovative Medicines | Audit e finanza | Ott 10, 2024 |
| Senior Product Manager, Digital Finance | Barcelona Gran Vía | Spagna | Finance | Corporate | Audit e finanza | Ott 01, 2024 |
| R2R Senior Specialist - Inventory | Selangor | Malaysia | Finance | CTS | Audit e finanza | Ott 02, 2024 |
| Senior Financial Reporting and Accounting Specialist | Prague | Repubblica Ceca | Finance | CTS | Audit e finanza | Lug 03, 2024 |
| P2P & T&E Specialist (Arabic Speaker) | Selangor | Malaysia | Finance | CTS | Audit e finanza | Lug 05, 2024 |
| ERP Assurance Senior Consultant | Selangor | Malaysia | Operations | CTS | Audit e finanza | Lug 17, 2024 |
| SAP Security Manager | Prague | Repubblica Ceca | Operations | CTS | Audit e finanza | Lug 22, 2024 |
| R2R Senior Specialist - GL & Reporting | Selangor | Malaysia | Finance | CTS | Audit e finanza | Ott 08, 2024 |
| Expert Analyst – Management Reporting | Prague | Repubblica Ceca | Finance | Corporate | Audit e finanza | Ott 08, 2024 |
| FRA Specialist - Asset Management | Prague | Repubblica Ceca | Finance | CTS | Audit e finanza | Ott 08, 2024 |
| Global Finance Master Data Sr Specialist | INSURGENTES | Messico | Finance | CTS | Audit e finanza | Ott 08, 2024 |
| Commercial BPA Manager | Montreal | Canada | International | Innovative Medicines | Audit e finanza | Ott 08, 2024 |
| LDC Core Enablement Business and IT Controls | Hyderabad (Office) | India | Operations | CTS | Audit e finanza | Ott 09, 2024 |
| Treasury & Cash Management Team Lead | Selangor | Malaysia | Finance | CTS | Audit e finanza | Ago 12, 2024 |
| R2R Senior Specialist - GL & Reporting | Selangor | Malaysia | Finance | CTS | Audit e finanza | Ago 19, 2024 |
| Manager, Financial Control & Compliance (FC&C) | Head Office (Japan) (Pharmaceuticals) | Giappone | Finance | CTS | Audit e finanza | Ott 06, 2024 |
| Digital Finance, Data & Tools Analyst | Barcelona Gran Vía | Spagna | Finance | CTS | Audit e finanza | Ott 11, 2024 |
| Financial Reporting & Accounting Specialist | Baarle Nassau | Paesi Bassi | Finance | Sandoz | Audit e finanza | Ott 11, 2024 |
| Senior Finance Specialist – Digital Analytics and Operations | Barcelona Gran Vía | Spagna | Finance | Innovative Medicines | Audit e finanza | Ott 11, 2024 |
| Investor Relations Executive Director | East Hanover | USA | Finance | Corporate | Audit e finanza | Ago 28, 2024 |
Pagination
- ‹ Previous page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- …
- 42
- › Next page
Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122